Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial.
- DOI
- 10.2147/opth.s263362
- Published
- 2020
- Container
- Clinical ophthalmology (Auckland, N.Z.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/opth.s263362,
title = {Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial.},
author = {Silverstein S and Yeu E and Tauber J and Guillon M and Jones L and Galarreta D and Srinivasan S and Manoj V},
year = {2020},
journal = {Clinical ophthalmology (Auckland, N.Z.)},
doi = {10.2147/opth.s263362},
url = {https://doi.org/10.2147/opth.s263362}
}RIS
TY - JOUR TI - Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial. AU - Silverstein S AU - Yeu E AU - Tauber J AU - Guillon M AU - Jones L AU - Galarreta D AU - Srinivasan S AU - Manoj V PY - 2020 JO - Clinical ophthalmology (Auckland, N.Z.) DO - 10.2147/opth.s263362 UR - https://doi.org/10.2147/opth.s263362 ER -
APA
S, S., E, Y., J, T., M, G., L, J., D, G., S, S., & V, M. (2020). Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial.. Clinical ophthalmology (Auckland, N.Z.). https://doi.org/10.2147/opth.s263362
Source records
- pubmed · retrieved 2026-09-24T19:49:00.361Z
- europe-pmc · retrieved 2026-09-24T19:49:00.383Z